İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2021

Clinical and Pathological Factors Predictıve of Bladder Cancer Recurrence in Patients with Upper Tract Prımary TCC

Niger J Clin Pract

YÖKSİS OpenAlex Açık erişim · diamond SJR Q3 JCR Q4 Atıf 3 Yüzdelik 49.3% FWCI 0.2
Yıl
2021
ISSN
1119-3077
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

ABSTRACT Objective: To evaluate predictive clinical and histopathological risk factors for bladder cancer recurrence in patients who underwent nephroureterectomy for primary upper urinary tract transitional cell carcinoma (TCC). Subjects and Methods: Data of 111 patients, who were diagnosed with upper urinary tract TCC and underwent nephroureterectomy were reviewed A total of 65 patients were included in the study, after excluding 34 patients. Results: Bladder cancer recurrence developed in 20 (30.7%) of the 65 patients under evaluation. The recurrence-free survival rates in the 1 st , 3 rd , and 5 th years were 78.4%, 70.7% and 69.2%, respectively. Lymphovascular invasion and a positive surgical margin were defined as risk factors for bladder cancer recurrence. In addition, patients with multiple tumors and low stage and grade pathology had a high rate of bladder cancer recurrence, although this was not statistically significant. Conclusion: After nephroureterectomy, a careful follow-up is required in terms of bladder tumor recurrence especially in patients with a positive surgical margin, lymphovascular invasion, low-grade tumors, or multifocal tumors.

Konular

  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urinary Bladder and Prostate Research

Birincil konu Bladder and Urothelial Cancer Treatments

Yazarlar

  1. MEHMET YOLDAŞ
  2. HAKAN TÜRK UŞAK ÜNİVERSİTESİ
  3. TUBA KUVVET YOLDAŞ